Addressing Neurologic Toxicities in CAR-T Therapy: Monitoring, Management, and Patient Communication

News
Video

The discussion focuses on monitoring and managing neurologic toxicities like ICANS in CAR-T therapy, highlighting tools for early detection, effective management strategies, and approaches to communicating risks with patients and caregivers.

Video content above is prompted by the following:

  • Neurologic toxicities, such as ICANS, pose unique challenges. How do you approach monitoring and management of these events in your practice?
  • What tools or assessment methods help you identify early signs of neurotoxicity?
  • How do you communicate these risks to patients and their caregivers?
Recent Videos
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Related Content